Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

23847studies shown

Showing 22,705-22,716 of 23,847

Drug study icon

CompletedNCT00300742

Topiramate for Alcohol Dependent Binge-Eating Disordered Individuals

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Charlottesville

Eating disordersDrugOver 18 Years

Countries: United States
Sponsor: University of Virginia
Condition: Eating disorders

Drug study icon

CompletedNCT00345371

Topiramate for Methamphetamine Dependence - 1

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Costa Mesa

AddictionDrugFrom 18 Years to 99 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Addiction

Drug study icon

CompletedNCT00203463

Topiramate in the Treatment of PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In Tuscaloosa

PTSDDrugOver 18 Years

Countries: United States
Sponsor: Tuscaloosa Research & Education Advancement Corporation
Condition: PTSD

Drug study icon

CompletedNCT00208130

Topiramate in the Treatment of PTSD in Civilians

This summary needs review. Please check the official study record and contact the research team for details.

In Omaha

PTSDDrugFrom 19 Years to 64 Years

Countries: United States
Sponsor: Creighton University
Condition: PTSD

Drug study icon

CompletedNCT00802412

Topiramate to Aid Smoking Cessation in Alcohol Dependent Men

This summary needs review. Please check the official study record and contact the research team for details.

In San Diego

AddictionDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Addiction

Drug study icon

CompletedNCT00223626

Topiramate to Reduce Cocaine Dependence

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Charlottesville

AddictionDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: Bankole Johnson
Condition: Addiction

Drug study icon

TerminatedNCT03018704

Topiramate Treatment of Alcohol Use Disorders in African Americans

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Decatur

AddictionDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Addiction

Drug study icon

CompletedNCT01087736

Topiramate Treatment of Alcohol Use Disorders in Veterans With PTSD (PTSD): A Controlled study of Augmentation Therapy

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco

PTSDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of California, San Francisco
Condition: PTSD

Drug study icon

CompletedNCT00237289

Topiramate Versus Placebo as add-on Treatment in people with Bipolarity in the Outpatient Setting

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed

BipolarityDrugFrom 18 Years to 70 Years

Countries
Sponsor: Ortho-McNeil Neurologics, Inc.
Condition: Bipolarity

Drug study icon

CompletedNCT05663749

Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

In Bhubaneswar

SchizophreniaDrugOver 25 Years

Countries: India
Sponsor: All India Institute of Medical Sciences, Bhubaneswar
Condition: Schizophrenia

Drug study icon

CompletedNCT00394095

Topiramate vs. Placebo in Preventing Weight Gain in Bipolarity Treated With Olanzapine

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.

In Cincinnati

BipolarityDrugFrom 10 Years to 18 Years

Countries: United States
Sponsor: University of Cincinnati
Condition: Bipolarity

Behavioral study icon

TerminatedNCT03562520

Toward Exercise as Medicine for Adolescents With Bipolarity

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Toronto

BipolarityBehavioralFrom 13 Years to 21 Years

Countries: Canada
Sponsor: Sunnybrook Health Sciences Centre
Condition: Bipolarity

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.